Literature DB >> 17646736

Dendritic cells: a conductor of T cell differentiation.

Norimitsu Kadowaki1.   

Abstract

Induction of different types of adaptive immune responses depending on the nature of antigens and the environmental context is crucial to cope with a variety of pathogens and concurrently to avoid pathological reaction to self antigens. Recent studies have been elucidating that the diversity of immune responses is critically controlled by dendritic cells (DCs). Two DC subsets have been identified in humans: myeloid DCs and plasmacytoid DCs. The DC subsets induce different types of adaptive immune responses depending on environmental factors. Interleukin (IL)-12 from myeloid DCs is a dominant factor for the induction of a Th1 response, whereas OX40 ligand on myeloid DCs is important for the induction of a Th2 response. Furthermore, inducible costimulator (ICOS) ligand on plasmacytoid DCs is critical for the induction of IL-10-producing regulatory T cells. Elucidating cellular and molecular mechanisms by which functions of the two DC subsets are modulated will lead to understanding the pathogenesis of various immune-related diseases and to developing novel immunological therapies.

Entities:  

Mesh:

Year:  2007        PMID: 17646736     DOI: 10.2332/allergolint.R-07-146

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  31 in total

1.  Expression and functional analysis of toll-like receptors of peripheral blood cells in asthmatic patients: implication for immunopathological mechanism in asthma.

Authors:  Samantha W M Lun; C K Wong; Fanny W S Ko; David S C Hui; Christopher W K Lam
Journal:  J Clin Immunol       Date:  2008-12-06       Impact factor: 8.317

2.  Effects of dendritic cell-activated and cytokine-induced killer cell therapy on 22 children with acute myeloid leukemia after chemotherapy.

Authors:  Yan Bai; Jin-E Zheng; Nan Wang; He-Hua Cai; Li-Na Zhai; Yao-Hui Wu; Fang Wang; Run-Ming Jin; Dong-Feng Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

3.  Combination of p53-DC vaccine and rAd-p53 gene therapy induced CTLs cytotoxic against p53-deleted human prostate cancer cells in vitro.

Authors:  H Saito; K Kitagawa; T Yoneda; Y Fukui; M Fujsawa; D Bautista; T Shirakawa
Journal:  Cancer Gene Ther       Date:  2017-06-16       Impact factor: 5.987

Review 4.  The role of dendritic cells in CNS autoimmunity.

Authors:  Alla L Zozulya; Benjamin D Clarkson; Sonja Ortler; Zsuzsanna Fabry; Heinz Wiendl
Journal:  J Mol Med (Berl)       Date:  2010-03-09       Impact factor: 4.599

Review 5.  Pattern response of dendritic cells in the tumor microenvironment and breast cancer.

Authors:  Alessandra da Cunha; Marcia A Michelin; Eddie Fc Murta
Journal:  World J Clin Oncol       Date:  2014-08-10

6.  Designing the optimal vaccine: the importance of cytokines and dendritic cells.

Authors:  Penelope A Morel; Michael S Turner
Journal:  Open Vaccine J       Date:  2010

7.  Bile acids induce monocyte differentiation toward interleukin-12 hypo-producing dendritic cells via a TGR5-dependent pathway.

Authors:  Riko Ichikawa; Tetsuro Takayama; Kazuaki Yoneno; Nobuhiko Kamada; Mina T Kitazume; Hajime Higuchi; Katsuyoshi Matsuoka; Mitsuhiro Watanabe; Hiroshi Itoh; Takanori Kanai; Tadakazu Hisamatsu; Toshifumi Hibi
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

8.  Antigen-presenting dendritic cells rescue CD4-depleted CCR2-/- mice from lethal Histoplasma capsulatum infection.

Authors:  Wendy A Szymczak; George S Deepe
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

9.  Functional impairment of human myeloid dendritic cells during Schistosoma haematobium infection.

Authors:  Bart Everts; Ayola A Adegnika; Yvonne C M Kruize; Hermelijn H Smits; Peter G Kremsner; Maria Yazdanbakhsh
Journal:  PLoS Negl Trop Dis       Date:  2010-04-20

10.  Role of CD44 in the differentiation of Th1 and Th2 cells: CD44-deficiency enhances the development of Th2 effectors in response to sheep RBC and chicken ovalbumin.

Authors:  Hongbing Guan; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.